Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-12-17 | New | $200,000 | $200,000 | Other | 06b | SEC link |
| 2023-09-11 | Amended | $310,000 | $260,000 | Equity Only | 06b | SEC link |
| 2023-09-11 | Amended | $162,778 | $112,778 | Debt Only | 06b | SEC link |
| 2022-10-31 | New | $50,000 | $50,000 | Debt Only | 06b | SEC link |
| 2022-10-31 | New | $50,000 | $50,000 | Equity Only | 06b | SEC link |
| 2021-04-23 | New | $250,000 | Unknown | Equity Only | SEC link |
| Name | Role |
|---|---|
| Steven Baker | Executive |
| Scott Filer | Director, Executive |
| Matthew Hansen | Director, Executive |
| Robert Jenks | Executive |
| Andrew Kibler | Director, Executive |
| David Sheridan | Director, Executive |